Ligand profile
ZINC93985
Virtual-screening candidate from ZINC.
Bound to: HT085_RS00010 — DNA polymerase III subunit beta
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC93985- UniProt (similar protein)
P0A988- Tanimoto
- 0.786
- Target protein
- HT085_RS00010
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 58.9
- −1 ≤ LogP ≤ 5 2.73
- MW ≤ 500 Da 248.7
- LogP ≤ 5 2.73
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 1
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 58.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21
InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)/t9-/m0/s1InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)/t9-/m0/s1
FUZYTVDVLBBXDL-VIFPVBQESA-NFUZYTVDVLBBXDL-VIFPVBQESA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 2J2
- Homolog
- P0A988
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC93985 →
- ZINC ZINC20 ZINC93985 →
- UniProt UniProt P0A988 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC93985”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00010.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).